Inventor · disambiguated record
David Lechuga-Ballesteros
Also filed as: LECHUGA-BALLESTEROS DAVID
23 granted patents·25 pending applications·589 citations·filing 1999–2024
96Inventor score
Files withPEARL THERAPEUTICS INC10NEKTAR THERAPEUTICS6ASTRAZENECA PHARMACEUTICALS LP5MEDIMMUNE LTD3VEHRING REINHARD3
Top patents by PatentIndex Score
48 records- 0199US6518239B1Dry powder compositions having improved dispersivityINHALE THERAPEUTIC SYST·Filed 2000·Granted Feb 11, 2003·377 cites·40 claims
- 0295US6835372B2Compositions comprising an active agentNEKTAR THERAPEUTICS·Filed 2002·Granted Dec 28, 2004·53 cites·27 claims
- 0392US7482024B2Compositions comprising an active agentNEKTAR THERAPEUTICS·Filed 2004·Granted Jan 27, 2009·32 cites·19 claims
- 0490US8324266B2Compositions, methods and systems for respiratory delivery of two or more active agentsVEHRING REINHARD·Filed 2011·Granted Dec 4, 2012·11 cites·30 claims
- 0589US8815258B2Compositions, methods and systems for respiratory delivery of two or more active agentsVEHRING REINHARD·Filed 2011·Granted Aug 26, 2014·9 cites·57 claims
- 0689US7326691B2Compositions comprising amphotericin B, methods, and systemsNEKTAR THERAPEUTICS·Filed 2005·Granted Feb 5, 2008·14 cites·6 claims
- 0787US8668934B2Pharmaceutical formulation comprising a water-insoluble active agentVEHRING REINHARD·Filed 2010·Granted Mar 11, 2014·11 cites·23 claims
- 0887US8067431B2Chemically modified small moleculesFISHBURN C SIMONE·Filed 2010·Granted Nov 29, 2011·8 cites·7 claims
- 0986US9539233B2Gallium formulation for the treatment and prevention of infectious diseasesOHTAKE SATOSHI·Filed 2010·Granted Jan 10, 2017·14 cites·4 claims
- 1085US11129794B2Chemically modified small moleculesNEKTAR THERAPEUTICS·Filed 2018·Granted Sep 28, 2021·1 cites·14 claims
- 1185US8703806B2Compositions, methods and propellant-based systems for respiratory delivery of glycopyrrolate and one or more active agentsPEARL THERAPEUTICS INC·Filed 2012·Granted Apr 22, 2014·6 cites·64 claims
- 1285US8241886B2Formulations for preservation of rotavirusTRUONG-LE VU·Filed 2008·Granted Aug 14, 2012·4 cites·22 claims
- 1385US2024024229A1Compositions, methods & systems for respiratory delivery of two or more active agentsPEARL THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1483US8637090B2Gallium formulation for the treatment and prevention of infectious diseasesOHTAKE SATOSHI·Filed 2010·Granted Jan 28, 2014·9 cites·13 claims
- 1575US9415009B2Compositions, methods and systems for respiratory delivery of two or more active agentsPEARL THERAPEUTICS INC·Filed 2014·Granted Aug 16, 2016·1 cites·49 claims
- 1675US6864369B2Crystalline pharmaceuticalABBOTT LAB·Filed 2003·Granted Mar 8, 2005·5 cites·14 claims
- 1775US2021267881A1Compositions, methods & systems for respiratory delivery of two or more active agentsPEARL THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1874US6413547B1Liquid crystal forms of cyclosporinINHALE THERAPEUTIC SYST·Filed 1999·Granted Jul 2, 2002·29 cites·24 claims
- 1973US12178911B2Dry powder formulations of thymic stromal lymphopoietin (TSLP)-binding antibodies and methods of use thereofMEDIMMUNE LTD·Filed 2022·Granted Dec 31, 2024·0 cites·5 claims
- 2073US7862834B2Pharmaceutical formulation comprising a water-insoluble active agentNOVARTIS PHARMA AG·Filed 2004·Granted Jan 4, 2011·5 cites·14 claims
- 2173US2025099386A1Dry Powder Formulations of Thymic Stromal Lymphopoietin (TSLP)-Binding Antibodies and Methods of Use ThereofMEDIMMUNE LTD·Filed 2024·Application pending·0 cites
- 2272US2024325298A1Compositions, methods and systems for aerosol drug deliveryASTRAZENECA PHARMACEUTICALS LP·Filed 2024·Application pending·0 cites
- 2370US2014303369A1Crystalline PharmaceuticalABBVIE INC·Filed 2014·Application pending·0 cites
- 2468US2023026203A1Compositions, methods and systems for aerosol drug deliveryASTRAZENECA PHARMACEUTICALS LP·Filed 2022·Application pending·0 cites
- 2568US2019358150A1Compositions, methods & systems for respiratory delivery of two or more active agentsPEARL THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2666US8501240B2Compositions comprising an active agentKUO MEI-CHANG·Filed 2008·Granted Aug 6, 2013·0 cites·39 claims
- 2765US2005124810A1Crystalline pharmaceuticalFiled 2004·Application pending·0 cites
- 2865US2024252432A1Compositions, methods and systems for aerosol drug deliveryASTRAZENECA PHARMACEUTICALS LP·Filed 2022·Application pending·0 cites
- 2965US2024358662A1Compositions, methods and systems for aerosol drug deliveryASTRAZENECA PHARMACEUTICALS LP·Filed 2022·Application pending·0 cites
- 3065US2024252440A1Compositions, methods and systems for aerosol drug deliveryASTRAZENECA PHARMACEUTICALS LP·Filed 2022·Application pending·0 cites
- 3164US2006182692A1Chemically modified small moleculesFISHBURN C S·Filed 2006·Application pending·0 cites
- 3264US2014377190A1Compositions, methods and systems for respiratory delivery of two or more active agentsPEARL THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 3363US2025057764A1Compositions, methods and systems for aerosol drug deliveryASTRAZENECA AB·Filed 2022·Application pending·0 cites
- 3461US11904053B2Dry powder formulations of thymic stromal lymphopoietin (TSLP)-binding antibodies and methods of use thereofMEDIMMUNE LTD·Filed 2020·Granted Feb 20, 2024·0 cites·19 claims
- 3561US11471468B2Methods and systems for conditioning of particulate crystalline materialsPEARL THERAPEUTICS INC·Filed 2020·Granted Oct 18, 2022·0 cites·29 claims
- 3661US8058433B2Crystalline pharmaceuticalDICKMAN DANIEL A·Filed 2006·Granted Nov 15, 2011·0 cites·39 claims
- 3761US2017000725A1Compositions, methods & systems for respiratory delivery of two or more active agentsPEARL THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3860US8796451B2Crystalline pharmaceuticalDICKMAN DANIEL A·Filed 2011·Granted Aug 5, 2014·0 cites·17 claims
- 3959US2012088745A1Chemically modified small moleculesFISHBURN C SIMONE·Filed 2011·Application pending·0 cites
- 4050US2006018840A1Aerosolizable formulation comprising nicotineNEKTAR THERAPEUTICS·Filed 2005·Application pending·0 cites
- 4149US2018344747A1Methods and systems for conditioning of particulate crystalline materialsPEARL THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4246US2006039985A1Methotrexate compositionsBENNETT DAVID B·Filed 2005·Application pending·0 cites
- 4346US2003130176A1Liquid crystal forms of cyclosporinFiled 2002·Application pending·0 cites
- 4444US2022401365A1Dry powder formulations containing leucine and trileucineASTRAZENECA AB·Filed 2020·Application pending·0 cites
- 4543US2015150787A1Compositions, methods & systems for respiratory delivery of three or more active agentsPEARL THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 4639US2006160871A1Stable non-crystalline formulation comprising losartanNEKTAR THERAPEUTICS·Filed 2005·Application pending·0 cites
- 4736US2011243988A1Methods and Compositions for Stabilization of a Virus VaccineARIDIS PHARMACEUTICALS·Filed 2010·Application pending·0 cites
- 4828US2011064723A1Formulation for room temperature stabilization of a live attenuated bacterial vaccineARIDIS PHARMACEUTICALS·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Lechuga-Ballesteros files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →